Related Experiment Video
Updated: May 7, 2026

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Enrichment analysis applied to disease prognosis
Catia M Machado1, Ana T Freitas, Francisco M Couto
1LaSIGE, Departamento de Informática, Faculdade de Ciências, Universidade de Lisboa, Lisboa, Portugal. cmachado@xldb.di.fc.ul.pt.
Enrichment analysis, applied to genetic data, can identify patient groups with hypertrophic cardiomyopathy (HCM) and predict disease events. This method aids in characterizing patient mutations and distinguishing those at higher risk.
Area of Science:
- Genomics and Bioinformatics
- Computational Biology
- Medical Informatics
Background:
- Enrichment analysis is a standard transcriptomics tool for identifying biological features in gene sets.
- Disease prognosis, especially for genetically influenced conditions, requires identifying patient subgroups and predicting disease-related events.
- Hypertrophic cardiomyopathy (HCM) serves as a case study due to its genetic basis and the need for improved prognostic tools.
Purpose of the Study:
- To adapt and apply enrichment analysis for disease prognosis, specifically identifying clinical and biological features that characterize patient groups.
- To assess the feasibility of using enrichment analysis as a preliminary step in a disease prognosis methodology.
- To distinguish between patient groups associated with disease-related events using data mining.
Main Methods:
- Utilized enrichment analysis on genetic data from hypertrophic cardiomyopathy (HCM) patients.
- Compared patients who experienced sudden cardiac death with those who did not.
- Performed enrichment profiling to characterize patient groups by mutations and differential enrichment to identify distinguishing features.
Main Results:
- Preliminary results show that enrichment analysis, using genetic data and Gene Ontology, successfully characterizes HCM patient groups.
- Identified gene functions commonly altered in HCM patients, reflecting existing knowledge.
- The adapted enrichment analysis demonstrated potential in differentiating patient subgroups based on genetic mutations.
Conclusions:
- Enrichment analysis shows promise as a component of a disease prognosis methodology, particularly for genetically complex diseases like HCM.
- The preliminary findings suggest that this approach can characterize patient groups and identify features relevant to disease events.
- Further validation with clinical data alongside genetic data is necessary to fully evaluate the prognostic potential of enrichment analysis.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:35A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Kaplan-Meier Approach
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Assumptions of Survival Analysis